新型蓝叶多糖-桑坦复合凝用于库尔库明封装:增强稳定性和受控释放
Chuyan Wang1,2,3, Xiaoying Liu2, Yan Zhang2
1Anhui Ecological Fermentation Engineering Research Center for Functional Fruit Beverage, Fuyang Normal University, Fuyang 236037, China.
Foods (Basel, Switzerland)
|August 28, 2025
概括
研究人员开发了一种蓝叶多糖胺-桑坦 (BLP-XG) 复合凝,以改善黄素的输送. 这种新型凝增强了黄素的稳定性,保护它免受降解,并确保在小肠中有针对性的释放.
科学领域:
- 食品科学
- 材料科学
- 制药科学
背景情况:
- 库尔库是一种天然化合物,
- 开发有效的输送系统对于最大化黄素的治疗潜力至关重要.
研究的目的:
- 开发一种使用蓝叶多糖 (BLP-XG) 的新型复合凝系统,以增强黄素的保护和传递.
- 研究BLP-XG复合凝的结构性,热性和机械性.
- 评估复合凝系统的缩效率和释放特征.
主要方法:
- 通过结和静电相互作用制造BLP-XG复合凝.
- 凝特性,包括结构均性,热稳定性和粘性.
- 在模拟的胃和肠道条件下评估黄素封装率和体外释放研究.
- 评估黄素在复合凝中的抗紫外线降解稳定性.
主要成果:
- 与单元系统相比,BLP-XG复合凝具有更高的结构和热稳定性.
- 在2. 0%的BLP度下,黄素封装率最高为84. 23%.
- 复合凝有效地保护了黄素在胃的条件下,并促进了其在小肠中的释放.
- 蓝叶的多糖成分在紫外线照射下显著抑制了黄素的降解.
结论:
- BLP-XG复合凝是保护和输送黄素的有希望的系统,克服其固有的不稳定性.
- 这项研究强调了蓝叶多糖在开发先进的食品和药物输送系统方面的潜力.
- 这些发现为未来研究稳定和高效的黄素配方提供了基础.
更多相关视频
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222


